Compare Bakrieland Development Tbk. (ELTY) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bakrieland Development Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp35 (market cap 1.52T, 58.45M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: Bakrieland Development Tbk. is far larger — about 2.2× UBC Medical Indonesia Tbk.'s market cap, and Bakrieland Development Tbk. is more actively traded (58.45M versus 635.5K). Which is the better fit depends on your goals.
| ELTY | LABS | |
|---|---|---|
Market Cap | 1.52T | 691.25B |
Volume | 58.45M | 635.5K |
Lot | 584.46K | 6.36K |
Turnover | 2.03B | 110.15M |
Average Price | 34.68 | 173.33 |
Value | 2.03B | 110.15M |
Indicative Equilibrium Price | 35 | 174 |
Indicative Equilibrium Volume | 99.73K | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bakrieland Development Tbk.
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
